In vitro effect of dalteparin and argatroban on hemostasis in critically ill sepsis patients with new-onset thrombocytopenia

HIGHLIGHTS

• who: Dalteparin and collaborators from the Germany GermanyResearch Unit, Aarhus University Hospital, Aarhus, Denmark have published the research work: In vitro Effect of Dalteparin and Argatroban on Hemostasis in Critically Ill Sepsis Patients with New-Onset Thrombocytopenia, in the Journal: (JOURNAL)
• what: The aim of this study was to investigate the in_vitro effect of dalteparin and argatroban on thrombin generation and global dynamic hemostasis in blood samples from critically ill sepsis patients with new-onset thrombocytopenia. It was difficult to contextualize the findings to the literature, as prior studies focused on anticoagulant effects in healthy . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.